Note: Ingredients listed on restricted chemical lists
EC/CAS
265-151-9/64742-49-0
Name of the chemical
Naphtha (petroleum), hydrotreated light
Concentration
100%
General Information
Version
10.0
Revision date
2023-10-27
Product name
Heptan
CAS No.
64742-49-0
Emergency telephone
(dial 111, 24 h service
Icons in SDS
Company Information
company name
OQEMA ApS
e-mail address of the competent person responsible for the Safety Data Sheet
Oqema@Oqema.dk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H304, H315, H336, H411
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Flam. Liq. 2; H225, Highly flammable liquid and vapour. Asp. Tox. 1; H304, May be fatal if swallowed and enters airways. Skin Irrit. 2; H315, Causes skin irritation. STOT SE 3; H336, May cause drowsiness or dizziness. Aquatic Chronic 2; H411, Toxic to aquatic life with long lasting effects.
Signal word
Danger
Hazard statements
Highly flammable liquid and vapour. (H225) May be fatal if swallowed and enters airways. (H304) Causes skin irritation. (H315) May cause drowsiness or dizziness. (H336) Toxic to aquatic life with long lasting effects. (H411)
Precautionary statements
General: -
Prevention
Wash hands and exposed skin thoroughly after handling. (P264) Wear face protection/protective gloves/protective clothing. (P280)
Response
IF SWALLOWED: Immediately call a POISON CENTER/doctor. (P301+P310) Do NOT induce vomiting. (P331)
Storage
Store in a well-ventilated place. Keep cool. (P403+P235)
Disposal
Dispose of contents/container in accordance with local regulation (P501)
Hazardous Ingredients
Kulbrinter, C7, n-alkaner, isoalkaner, cykliske
Additional information
EUH066, Repeated exposure may cause skin dryness or cracking.
2.3 Other hazards
Additional warnings: This mixture/product does not contain any substances considered to meet the criteria classifying them as PBT and/or vPvB. This product does not contain any substances considered to be endocrine disruptors in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.
